Intravitreal implants in conjunction with photodynamic therapy to improve vision

Details for Australian Patent Application No. 2005244213 (hide)

Owner Allergan, Inc.

Inventors Whitcup, Scott M.; Weinberg, David V.; Burke, James A.

Agent Davies Collison Cave

Pub. Number AU-B-2005244213

PCT Pub. Number WO2005/110365

Priority 10/837,348 30.04.04 US; 11/112,523 22.04.05 US

Filing date 27 April 2005

Wipo publication date 24 November 2005

Acceptance publication date 17 June 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/00 (2006.01)

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110365 Priority application(s): WO2005/110365

17 June 2010 Application Accepted

  Published as AU-B-2005244213

14 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244214-Topical methadone compositions and methods for using the same

2005244211-Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies